| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/15/2004 | EP1456160A2 Vitamin d analogues |
| 09/15/2004 | EP1455827A1 Pecam-1 modulation |
| 09/15/2004 | EP1455791A1 Method for administering birb 796 bs |
| 09/15/2004 | EP1455788A1 1-glycinyl-4-aminomethyl-piperidine derivatives as factor xa inhibitors |
| 09/15/2004 | EP1455787A1 Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders |
| 09/15/2004 | EP1455580A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 09/15/2004 | EP1137653B1 Troxerutin with high trihydroxy-ethyl-rutin content and method for preparing same |
| 09/15/2004 | EP1054669B9 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 09/15/2004 | EP0889726B1 Novel cycloalkyl substituted imidazoles |
| 09/15/2004 | EP0733104B1 Purification of vitamin-k dependent proteins by membrane chromatography |
| 09/15/2004 | CN1529706A 哌嗪衍生物 Piperazine derivatives |
| 09/15/2004 | CN1529697A Tricyclic compounds useful as angiotensin II agonists |
| 09/15/2004 | CN1529617A Method for treaing autoimmune diseases in subject and in vitro diagnostic assays |
| 09/15/2004 | CN1529611A Use of IL-18 inhibitors for treatment or prevention of sepsis |
| 09/15/2004 | CN1529606A Preparation containing seleniter or selenate for treating wound |
| 09/15/2004 | CN1529603A Use of bile acid or bile salt fatty acid conjugates |
| 09/15/2004 | CN1528742A Compound for treating asthma, irritability an a inflammation and its intermediate |
| 09/15/2004 | CN1528451A Novel use of serum beta 2-glucoprotein I functional peptide segment for preparing thrombolytic medicine |
| 09/15/2004 | CN1528450A Use of serum beta 2-glucoprotein I functional peptide segment for preparing thrombolytic medicine |
| 09/15/2004 | CN1528449A Spirulina soft capsule and preparing method thereof |
| 09/15/2004 | CN1528361A use of plant spearmint for preparing medicine for treating upper respiratory tract system inflammation and hemorrhagic diseases |
| 09/15/2004 | CN1528360A Use of plant spearmint for peparing medicine for treating oral, Pharyngeal,esophagus inflammation and hemorrhagic diseases |
| 09/15/2004 | CN1528358A Use of plant spearmint for preparing medicine for treating urinary system inflammation and hemorrhagic diseases |
| 09/15/2004 | CN1528282A Use of tauring for preparine medicine enhancing leucocyte function |
| 09/15/2004 | CN1166677C Thiophene A2A receptor aganoists |
| 09/15/2004 | CN1166667C Imidazoimidazoles and trizoles as anti-inflammatory agents |
| 09/15/2004 | CN1166631C S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
| 09/15/2004 | CN1166629C Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same |
| 09/15/2004 | CN1166374C Hemiplegia treating pill |
| 09/15/2004 | CN1166370C New medicine for curing cerebral thrombosis |
| 09/14/2004 | US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury |
| 09/14/2004 | US6790953 Ether compounds |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790938 Human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins |
| 09/14/2004 | US6790845 Having an attached non-aromatic heterocyclic ring |
| 09/14/2004 | US6790828 Glycoprotein mimetics having ability for potentiation of thrombin-mediated activation of protein c and inability to activate thrombin-activatable fibrinolysis inhibitor (tafi), used as anticoagulants |
| 09/14/2004 | US6790826 Human haemopoietic maturation factor |
| 09/14/2004 | US6790628 Screening granulocyte colony stimulating factor(g-csf) poly-peptide analogs to use as g-csf replacements or antagonists; sensitizing cells to chemo/radiotherapy; treating hemato-poietic, neurological or reproduction related conditions |
| 09/10/2004 | WO2004076458A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | WO2004076429A1 Ethynyl derivatives serving as factor xa inhibitors |
| 09/10/2004 | WO2004075989A1 Fumed silica embolic compositions |
| 09/10/2004 | WO2004060362A3 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β |
| 09/10/2004 | WO2004060261A3 Novel factor viia inhibiting compounds |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004022128A3 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
| 09/10/2004 | WO2003101281A3 Method for reducing obstructive hydrocephalus |
| 09/10/2004 | WO2003061652A8 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | CA2788505A1 Polymer-factor viii moiety conjugates |
| 09/10/2004 | CA2517391A1 Ethynyl derivatives serving as factor xa inhibitors |
| 09/10/2004 | CA2516824A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/09/2004 | US20040176601 Benzimisazo[4,5-f]isoquinolinone derivatives |
| 09/09/2004 | US20040176473 Methods for delivering compounds into a cell |
| 09/09/2004 | US20040176446 Substituted amino dicarboxylic acid derivatives |
| 09/09/2004 | US20040176418 protease activated receptor (PAR) antagonists will be useful in the treatment of thrombotic, inflammatory, atherosclerotic and fibroproliferative disorders |
| 09/09/2004 | US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/09/2004 | US20040176411 especially useful for treating asthma and/or rhinitis; example compound N-[[[2-[4-(3,4-dichlorophenoxy)-1-piperidinyl]ethyl]amino]carbonyl]-4-methyl-benzenesulfonamide |
| 09/09/2004 | US20040176406 Pyrido [2,1-a] isoquinoline derivatives |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants |
| 09/09/2004 | US20040176361 2H-Isoquinolin-1-one derivatives as poly/ADP-ribose/ polymerase inhibitors |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/09/2004 | US20040176297 Characterizing and predicting responses; identifying most efficient, cost effective and/or convenient treatment regimens; computer profiling |
| 09/09/2004 | US20040176252 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 09/09/2004 | US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet |
| 09/09/2004 | US20040175378 Monoclonal antibody 3G4, or an antigen-binding region or immunoconjugate thereof, produced by hybridoma ATCC PTA 4545; binds to phosphatidyl serine |
| 09/09/2004 | DE10308907A1 Ethynylderivate Ethynylderivate |
| 09/08/2004 | EP1454632A1 Pharmaceutical preparation for the treatment of blood-clotting disorders containing factor VIII derived peptides |
| 09/08/2004 | EP1454140A2 Diagnosis and treatment of atherosclerosis |
| 09/08/2004 | EP1453966A1 Method for producing a recombinant polypeptide |
| 09/08/2004 | EP1453949A2 Production of cell suspensions |
| 09/08/2004 | EP1453832A1 Ring fused pyrazole derivatives |
| 09/08/2004 | EP1453829A1 Sulfonamido substituted imidazopyridines |
| 09/08/2004 | EP1453782A2 Substituted phenyl naphthalenes as estrogenic agents |
| 09/08/2004 | EP1453548A2 Compositions for and methods of treating and preventing sirs/sepsis |
| 09/08/2004 | EP1453547A2 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/08/2004 | EP1453528A2 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 09/08/2004 | EP1453525A1 Selective targeting of apoptotic cells |
| 09/08/2004 | EP1453522A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist |
| 09/08/2004 | EP1453511A1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
| 09/08/2004 | EP1453498A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production |
| 09/08/2004 | EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/08/2004 | EP1289972B1 Serine protease inhibitors |
| 09/08/2004 | EP1289950B1 Serine protease inhibitors |
| 09/08/2004 | EP1231931B1 Methods of treating inflammatory bowel disease using cholera toxin b subunit |
| 09/08/2004 | EP1191932B1 Production of agglomerates of inogatran and the compound inogatran anhydrate |
| 09/08/2004 | EP1126870B1 Use of vegf-c or vegf-d gene or protein to prevent restenosis |
| 09/08/2004 | EP1094712A4 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 09/08/2004 | EP1064021B1 Use of cysteinprotease inhibitors for the manufacture of a medicament for prevention and treatment of brain tissue impairment due to hypertensive encephalopathy or encephalothlipsis. |
| 09/08/2004 | EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors |
| 09/08/2004 | CN1527824A Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
| 09/08/2004 | CN1527727A Improved chelator conjugates |
| 09/08/2004 | CN1527726A Conjugates of erythropoietin (PEP) with polyethylene glycol (PEG) |
| 09/08/2004 | CN1527710A Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/08/2004 | CN1526730A Erythrocytosis factor and its production process |
| 09/08/2004 | CN1526726A Multisite mutant of human histiotype plasminogen activator |
| 09/08/2004 | CN1526417A Chinese medicine prepn for treating kidney swelling and ascites of broiler |